These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 6138598

  • 21. Improvement of erythropoiesis in uremic patients on CAPD.
    Lamperi S, Carozzi S, Icardi A.
    Int J Artif Organs; 1983 Jul; 6(4):191-4. PubMed ID: 6629524
    [Abstract] [Full Text] [Related]

  • 22. [Residual renal function and blood count in patients on continuous ambulatory peritoneal dialysis].
    Jovanović N, Lausević M, Stojimirović B.
    Srp Arh Celok Lek; 2006 Jul; 134(11-12):503-8. PubMed ID: 17304764
    [Abstract] [Full Text] [Related]

  • 23. Growth in children receiving continuous ambulatory peritoneal dialysis.
    Stefanidis CJ, Hewitt IK, Balfe JW.
    J Pediatr; 1983 May; 102(5):681-5. PubMed ID: 6341531
    [Abstract] [Full Text] [Related]

  • 24. Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis.
    Steele J, Billington T, Janus E, Moran J.
    Atherosclerosis; 1989 Sep; 79(1):47-50. PubMed ID: 2803346
    [Abstract] [Full Text] [Related]

  • 25. Red cell survival and red cell enzymes in patients on continuous peritoneal dialysis (CAPD).
    Hefti JE, Blumberg A, Marti HR.
    Clin Nephrol; 1983 May; 19(5):232-5. PubMed ID: 6851263
    [Abstract] [Full Text] [Related]

  • 26. Long-term continuous ambulatory peritoneal dialysis.
    Flynn CT.
    Proc Eur Dial Transplant Assoc; 1983 May; 20():700-4. PubMed ID: 6657690
    [Abstract] [Full Text] [Related]

  • 27. [Comparison of the ability to control anemia in patients on hemodialysis and peritoneal dialysis considering iron reserves and plasma erythropoietin].
    Majdan M, Ksiazek A, Spasiewicz D.
    Pol Arch Med Wewn; 1996 Apr; 95(4):307-12. PubMed ID: 8755836
    [Abstract] [Full Text] [Related]

  • 28. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
    Pietrzak I, Bladek K, Bulikowski W.
    Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
    [Abstract] [Full Text] [Related]

  • 29. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J, Boner G, Rosenfeld J, Waller A, Iaina A, Eliahou HE.
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [Abstract] [Full Text] [Related]

  • 30. [Content of thiamin in plasma and erythrocytes in patients with end stage renal disease].
    Pietrzak I, Baczyk K, Młynarczyk M, Kaczmarek M.
    Przegl Lek; 1996 Oct; 53(5):423-6. PubMed ID: 8754406
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
    Hampson G, Vaja S, Evans C, Chesters CA, Pettit R, Evans W, Thomas D, Seed PT, Fraser WD.
    Nephron; 2002 May; 91(1):94-102. PubMed ID: 12021525
    [Abstract] [Full Text] [Related]

  • 32. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis.
    Chandra M, McVicar M, Clemons G, Mossey RT, Wilkes BM.
    Nephron; 1987 May; 46(3):312-5. PubMed ID: 3627325
    [Abstract] [Full Text] [Related]

  • 33. Ferrokinetics in patients on CAPD: influence of CAPD on the anemia of uremia.
    Lee HB, Koh SW, Park HS.
    Korean J Intern Med; 1986 Jan; 1(1):54-9. PubMed ID: 15759377
    [Abstract] [Full Text] [Related]

  • 34. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
    Sotirakopoulos N, Tsitsios T, Stambolidou M, Athanasiou G, Peiou M, Kokkinou V, Mavromatidis K.
    Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
    [Abstract] [Full Text] [Related]

  • 35. Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study.
    Matsumura K, Okumiya T, Sugiura T, Takahashi N, Yamamoto Y, Kikuchi S, Fujii K, Otagaki M, Shiojima I.
    BMC Nephrol; 2020 Sep 29; 21(1):418. PubMed ID: 32993543
    [Abstract] [Full Text] [Related]

  • 36. [Continuous ambulatory peritoneal dialysis, advantages and disadvantages].
    Descoeudres C.
    Schweiz Med Wochenschr; 1981 Feb 28; 111(9):293-7. PubMed ID: 7221530
    [Abstract] [Full Text] [Related]

  • 37. Three years' experience of continuous ambulatory peritoneal dialysis.
    Chan MK, Baillod RA, Chuah P, Sweny P, Raftery MJ, Varghese Z, Moorhead JF.
    Lancet; 1981 Jun 27; 1(8235):1409-12. PubMed ID: 6113364
    [Abstract] [Full Text] [Related]

  • 38. Characteristics of the hematocrit response to continuous ambulatory peritoneal dialysis.
    Steiner RW.
    Arch Intern Med; 1984 Apr 27; 144(4):728-32. PubMed ID: 6712371
    [Abstract] [Full Text] [Related]

  • 39. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T, Puttipittayathorn N, Leelahavanichkul A, Lieusuwan S, Katavetin P, Mahatanan N, Sriudom K, Chirananthavat T, Thongbor N, Eiam-Ong S.
    J Med Assoc Thai; 2011 Sep 27; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [Abstract] [Full Text] [Related]

  • 40. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O, Stenvinkel P, Berglund L, Tranoeus A, Lindholm B.
    Nephron; 1996 Sep 27; 72(2):135-44. PubMed ID: 8684516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.